Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations.
Sikkes SAM, Tang Y, Jutten RJ, Wesselman LMP, Turkstra LS, Brodaty H, Clare L, Cassidy-Eagle E, Cox KL, Chételat G, Dautricourt S, Dhana K, Dodge H, Dröes RM, Hampstead BM, Holland T, Lampit A, Laver K, Lutz A, Lautenschlager NT, McCurry SM, Meiland FJM, Morris MC, Mueller KD, Peters R, Ridel G, Spector A, van der Steen JT, Tamplin J, Thompson Z; ISTAART Non-pharmacological Interventions Professional Interest Area; Bahar-Fuchs A. Sikkes SAM, et al. Among authors: peters r. Alzheimers Dement. 2021 Feb;17(2):255-270. doi: 10.1002/alz.12188. Epub 2020 Nov 20. Alzheimers Dement. 2021. PMID: 33215876 Free PMC article. Review.
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus.
Anstey KJ, Peters R, Zheng L, Barnes DE, Brayne C, Brodaty H, Chalmers J, Clare L, Dixon RA, Dodge H, Lautenschlager NT, Middleton LE, Qiu C, Rees G, Shahar S, Yaffe K. Anstey KJ, et al. Among authors: peters r. J Alzheimers Dis. 2020;78(1):3-12. doi: 10.3233/JAD-200674. J Alzheimers Dis. 2020. PMID: 32925063 Free PMC article.
Intergenerational Programmes bringing together community dwelling non-familial older adults and children: A Systematic Review.
Peters R, Ee N, Ward SA, Kenning G, Radford K, Goldwater M, Dodge HH, Lewis E, Xu Y, Kudrna G, Hamilton M, Peters J, Anstey KJ, Lautenschlager NT, Fitzgerald A, Rockwood K. Peters R, et al. Among authors: peters j. Arch Gerontol Geriatr. 2021 May-Jun;94:104356. doi: 10.1016/j.archger.2021.104356. Epub 2021 Jan 28. Arch Gerontol Geriatr. 2021. PMID: 33567363 Free PMC article. Review.
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report.
Jicha GA, Abner EL, Arnold SE, Carrillo MC, Dodge HH, Edland SD, Fargo KN, Feldman HH, Goldstein LB, Hendrix J, Peters R, Robillard JM, Schneider LS, Titiner JR, Weber CJ; Clinical Trial Advancement & Methodology Professional Interest Area of the International Society to Advance Alzheimer's Research and Treatment (ISTAART). Jicha GA, et al. Among authors: peters r. Alzheimers Dement. 2022 Jun;18(6):1109-1118. doi: 10.1002/alz.12461. Epub 2021 Sep 29. Alzheimers Dement. 2022. PMID: 34590417 Free PMC article.
Evaluation of High Cholesterol and Risk of Dementia and Cognitive Decline in Older Adults Using Individual Patient Meta-Analysis.
Peters R, Xu Y, Antikainen R, Beckett N, Gussekloo J, Jagger C, Jukema JW, Keinanen-Kiukaanniemi S, Rydén L, Skoog I, Staessen JA, Thijs L, Trompet S, Tully PJ, Tzourio C, Anstey KJ. Peters R, et al. Dement Geriatr Cogn Disord. 2021;50(4):318-325. doi: 10.1159/000519452. Epub 2021 Oct 26. Dement Geriatr Cogn Disord. 2021. PMID: 34700321
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?
Peters R, Dodge HH, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Anderson CS, Anstey KJ. Peters R, et al. Alzheimers Dement. 2022 Mar;18(3):507-512. doi: 10.1002/alz.12393. Epub 2021 Nov 2. Alzheimers Dement. 2022. PMID: 34726352
Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.
Peters R, Breitner J, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Weber C, Anderson C, Anstey KJ, Dodge HH. Peters R, et al. Alzheimers Dement (N Y). 2021 Dec 8;7(1):e12202. doi: 10.1002/trc2.12202. eCollection 2021. Alzheimers Dement (N Y). 2021. PMID: 34934803 Free PMC article. Review.
Exercise interventions to reduce anxiety in mid-life and late-life anxiety disorders and subthreshold anxiety disorder: a systematic review.
Chong TWH, Kootar S, Wilding H, Berriman S, Curran E, Cox KL, Bahar-Fuchs A, Peters R, Anstey KJ, Bryant C, Lautenschlager NT. Chong TWH, et al. Among authors: peters r. Ther Adv Psychopharmacol. 2022 Jul 7;12:20451253221104958. doi: 10.1177/20451253221104958. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 35833057 Free PMC article. Review.
3,575 results